⌕
Madrigal Pharmaceuticals · MDGL · Nasdaq
Tenet 32 · Weak
Compare
$421.99−0.46%At closeTenet 32 · Weak
$421.99−1.97 (−0.46%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Madrigal Pharmaceuticals (MDGL) Institutional Ownership

13F filers reported holding 12.0% of Madrigal Pharmaceuticals (MDGL) shares as of Sep 30, 2026, across 226 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
12.0%
Sep 30, 2026
13F filers
226
quarter ended Sep 30, 2026
13F value
$1.4B
2.8M shares
Quarter's fund flow
Mild accumulation
51 new · 19 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (51 new · 73 increased · 58 reduced · 19 closed · 25 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 226 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 6, 2026Kelley Shannon TGeneral CounselDisposed · Open-market sale1,077$400.00↗
Nov 6, 2026BAKER BROS. ADVISORS LPdirectorAcquired · Open-market buy60,400$383.02↗
Nov 6, 2026BAKER BROS. ADVISORS LPdirectorAcquired · Open-market buy13,740$388.29↗
Nov 6, 2026BAKER BROS. ADVISORS LPdirectorAcquired · Open-market buy2,000$396.61↗
Nov 4, 2026BAKER BROS. ADVISORS LPdirectorAcquired · Open-market buy5,586$366.99↗
Nov 4, 2026BAKER BROS. ADVISORS LPdirectorAcquired · Open-market buy10,080$368.11↗
Sep 11, 2026Sibold William JohnPresident and CEODisposed · Open-market sale60$533.09↗
Sep 11, 2026Sibold William JohnPresident and CEODisposed · Open-market sale106$534.06↗
Sep 11, 2026Sibold William JohnPresident and CEODisposed · Open-market sale218$535.94↗
Sep 11, 2026Sibold William JohnPresident and CEODisposed · Open-market sale160$537.62↗
Sep 11, 2026Sibold William JohnPresident and CEODisposed · Open-market sale687$540.59↗
Sep 11, 2026Sibold William JohnPresident and CEODisposed · Open-market sale368$541.64↗
Sep 11, 2026Sibold William JohnPresident and CEODisposed · Open-market sale1,202$542.60↗
Sep 11, 2026Sibold William JohnPresident and CEODisposed · Open-market sale1,539$544.02↗
Sep 11, 2026Sibold William JohnPresident and CEODisposed · Open-market sale761$544.83↗
Sep 11, 2026Sibold William JohnPresident and CEODisposed · Open-market sale120$546.38↗
Sep 9, 2026Sibold William JohnPresident and CEODisposed · Open-market sale131$527.88↗
Sep 9, 2026Sibold William JohnPresident and CEODisposed · Open-market sale347$529.27↗
Sep 9, 2026Sibold William JohnPresident and CEODisposed · Open-market sale522$530.23↗
Sep 9, 2026Sibold William JohnPresident and CEODisposed · Open-market sale368$531.99↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Madrigal Pharmaceuticals do institutions hold?

13F filers reported holding 12.0% of Madrigal Pharmaceuticals' shares as of Sep 30, 2026, across 226 filers.

How many 13F filers hold Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals was held by 226 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.